Results 31 to 40 of about 2,472,617 (310)

Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.

, 2012
BACKGROUND: Treatment options for drug-resistant tuberculosis (DR-TB) are limited. Linezolid has been successfully used to treat DR-TB in adults, but there are few case reports of its use in children for TB.
Hallbauer, UM, Hesseling, AC, Rose, PC, Schaaf, HS, Seddon, JA   +4 more
core   +1 more source

A prospective cohort study comparing the reactogenicity of trivalent influenza vaccine in pregnant and non-pregnant women [PDF]

, 2015
Background: Influenza vaccination during pregnancy can prevent serious illness in expectant mothers and provide protection to newborns; however, historically uptake has been limited due to a number of factors, including safety concerns.
A Legge, AK Regan, AL Naleway, Annette K Regan, C Yuet Sheung Yuen, CA Peschken, Caroline Talbot, Christopher C Blyth, D Carcione, DB Fell, Donna B Mak, EO Kharbanda, Geoffrey Shellam, IH Russo, JD Nordin, JD Nordin, JR Russo, KE Wiley, Lauren Tracey, M Henninger, MJ Bartlett, P Duclos, Paul V Effler, Peter C Richmond, PL Moro, PV Effler, RA Bednarczyk, SE Haberg, SE Taksdal, World Health Organisation   +29 more
core   +2 more sources

Research and Discussion on the Supervision of Registration and Sales Units for In Vitro Diagnostic Reagents

Zhongguo yiliao qixie zazhi
This study reviewed the pre-market regulatory requirements for the division of registration units, registration and filing status, as well as the actual sales and usage status of in vitro diagnostic reagent registration units from the perspective of full
Qinfang DONG, Jun YANG, Lingang JIN, Ling LI, Qiying AIXINJUELUO, Xiaohe YANG   +5 more
doaj   +1 more source

Reporting of Clinical Adverse Events Scale: a measure of doctor and nurse attitudes to adverse event reporting [PDF]

, 2008
Objective: To develop a validated measure of professionals' attitudes towards clinical adverse event reporting (CAER). Design: Cross-sectional survey with follow-up. Participants: 201 doctors and nurse/nurse-midwives undergoing postqualification training
Bekker, H.L., Fylan, F., Wilson, B.
core   +2 more sources

Oral herbal therapies for treating osteoarthritis (review) [PDF]

, 2014
Background Medicinal plant products are used orally for treating osteoarthritis. Although their mechanisms of action have not yet been elucidated in full detail, interactions with common inflammatory mediators provide a rationale for using them to ...
Cameron, Melainie, Chrubasik, Sigrun
core   +1 more source

Adverse events

British Journal of Surgery, 2004
No room for ...
openaire   +2 more sources

Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer [PDF]

, 2007
Background Selective cyclooxygenase inhibitors may retard the progression of cancer, but they have enhanced thrombotic potential. We report on cardiovascular adverse events in patients receiving rofecoxib to reduce rates of recurrence of colorectal ...
Andrew Stanley, Christopher C. McConkey, Claire Iveson, David J. Kerr, Giovannucci E, Janet A. Dunn, Joanne C. Stokes, Justine L. Smith, Michael J. Langman, Oshima M, Patrick Julier, Rachel S.J. Midgley, Ravi Duvvuri, Thun MJ   +13 more
core   +1 more source

An Australian perspective SADI-S/OADS: adverse events and nutritional deficiencies [PDF]

, 2019
Background: The rate of adverse events and the impact of single anastomosis duodenal-ileal bypass with sleeve gastrectomy or one anastomosis duodenal switch (SADI-S/OADS) on nutritional deficiencies has not been reported in the Australian population ...
Jordaan, Jacobus, Jordaan, Nova, Marshall, Skye   +2 more
core   +1 more source

Topical treatment of peripheral neuropathic pain: applying the evidence [PDF]

, 2017
Patients with peripheral neuropathic pain (NP) may only achieve partial pain relief with currently recommended first-line oral treatments, which are also associated with systemic adverse events.
Cruccu, Giorgio, Sommer, Claudia
core   +1 more source

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source